Login / Signup

Efficacy of short-term combination of intralymphatic allergen immunotherapy and lokivetmab treatment in canine atopic dermatitis: A double-blinded, controlled, randomised study.

Kelly van AmersfortJohannes C M VernooijAnnette van der Lee
Published in: Veterinary dermatology (2023)
The efficacy of this ILIT protocol was comparable with LVM monotherapy at six months. When ILIT was continued with SCIT, a favourable response was seen.
Keyphrases
  • atopic dermatitis
  • open label
  • clinical trial
  • combination therapy
  • randomized controlled trial
  • study protocol